OrganiGram Holdings (OGI) stock forecast for 2025
Last update: 05-14-2022, 5:34
Sector: HealthcareThe share price of OrganiGram Holdings Inc. (OGI) now
What analysts predict:: $2.8
52-week high/low: $3.52 / $1.1
50/200 Day Moving Average: $1.5 / $1.951
This figure corresponds to the average price over the previous 50/200 days. For OrganiGram Holdings stocks, the 50-day moving average is the resistance level today.
For OrganiGram Holdings stocks, the 200-day moving average is the resistance level today.
Are you interested in OrganiGram Holdings stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the OrganiGram Holdings stock price in 2025. How much will one OrganiGram Holdings share be worth in 2025?
Is it worth taking profit / loss on OrganiGram Holdings stock now or waiting? What are analysts' forecasts for OrganiGram Holdings stock?
We forecast OrganiGram Holdings stock performance using neural networks based on historical data on OrganiGram Holdings stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
The OrganiGram Holdings stock prediction results are shown below and presented as a graph, table and text information.
OrganiGram Holdings stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for OrganiGram Holdings analysts is $2.8.
Today 200 Day Moving Average is the resistance level (1.951 $).
50 Day Moving Average is the resistance level (1.5 $).
Historical and forecast chart of OrganiGram Holdings stock
The chart below shows the historical price of OrganiGram Holdings stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the OrganiGram Holdings stock price can be found in the table below.
OrganiGram Holdings (OGI) Forecast for 2025
Month | Target | Pes. | Opt. | Vol., % |
---|---|---|---|---|
Jan | 1.92 | 1.74 | 2.05 | 15.47 % |
Feb | 2.26 | 2.10 | 2.56 | 17.98 % |
Mar | 2.36 | 2.24 | 2.62 | 14.43 % |
Apr | 2.40 | 2.08 | 2.67 | 21.83 % |
May | 2.43 | 2.15 | 2.63 | 18.39 % |
Jun | 2.50 | 2.38 | 2.75 | 13.27 % |
Jul | 2.50 | 2.18 | 2.86 | 23.83 % |
Aug | 2.48 | 2.29 | 2.74 | 16.46 % |
Sep | 2.16 | 2.01 | 2.29 | 12.23 % |
Oct | 2.22 | 2.05 | 2.42 | 15.38 % |
Nov | 2.09 | 1.87 | 2.20 | 14.91 % |
Dec | 2.07 | 1.82 | 2.27 | 19.59 % |
OrganiGram Holdings information and performance
Organigram Holdings Inc is a licensed medical marijuana manufacturer.
OrganiGram Holdings Address
35A ENGLISH DR., MONCTON, NB, CA
Market Capitalization: 362 268 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: - $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: None
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: None
Price/earnings to growth
DPS: N/A
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: N/A
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: -0.091
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 1.174
Trailing PE: -
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 28.99
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 2.922
Enterprise Value (EV) /Revenue
EV To EBITDA: -
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 313690000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
OrganiGram Holdings price target for 2021 by month
Target values for the price of one OrganiGram Holdings share for Jan 2025.
Pessimistic target level: 1.74
Optimistic target level: 2.05
Target values for the price of one OrganiGram Holdings share for Feb 2025.
Pessimistic target level: 2.10
Optimistic target level: 2.56
Target values for the price of one OrganiGram Holdings share for Mar 2025.
Pessimistic target level: 2.24
Optimistic target level: 2.62
Target values for the price of one OrganiGram Holdings share for Apr 2025.
Pessimistic target level: 2.08
Optimistic target level: 2.67
Target values for the price of one OrganiGram Holdings share for May 2025.
Pessimistic target level: 2.15
Optimistic target level: 2.63
Target values for the price of one OrganiGram Holdings share for Jun 2025.
Pessimistic target level: 2.38
Optimistic target level: 2.75
Target values for the price of one OrganiGram Holdings share for Jul 2025.
Pessimistic target level: 2.18
Optimistic target level: 2.86
Target values for the price of one OrganiGram Holdings share for Aug 2025.
Pessimistic target level: 2.29
Optimistic target level: 2.74
Target values for the price of one OrganiGram Holdings share for Sep 2025.
Pessimistic target level: 2.01
Optimistic target level: 2.29
Target values for the price of one OrganiGram Holdings share for Oct 2025.
Pessimistic target level: 2.05
Optimistic target level: 2.42
Target values for the price of one OrganiGram Holdings share for Nov 2025.
Pessimistic target level: 1.87
Optimistic target level: 2.20
Target values for the price of one OrganiGram Holdings share for Dec 2025.
Pessimistic target level: 1.82
Optimistic target level: 2.27
Related stocks from Healthcare sector
All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.